论文部分内容阅读
Objective: To determine if anisodamine is able to augment mucosal perfusion during gut ischemia-reperfusion (I/R). Methods: A jejunal sac was formed in Sprague Dawley rat. A Laser Doppler probe and a tonometer were inserted into the sac which was filled with saline. The superior mesenteric artery was occluded (SMAO) for 60minutes followed by 90 minutes of reperfusion. At the end of 60 minutes of SMAO, either 0.2mg/kg of anisodmine or dobutamine was injected into the jejunal sac. Laser Doppler mucosal blood flow and regional PCO2 (PrCO2) measurements were made. Results: Mucosal blood flow was significantly increased at 30,60 and 90 minutes of reperfusion (R30, R60, R90 ) when intraluminal anisodamine or dobutamine was introduced compared to intraluminal saline only (44±3.3)% or (48±4.1)% vs. (37±2.6) % at R30, (57±5.0)% or (56±4.7)% vs. (45±2.7)% at R60, (64±3.3) % or (56 ± 4.2) % vs. (48 ± 3.4) % at R90 , respectively P＜0.05). Blood flow changes were also reflected by lowering of jejunal PrCO2 measurements after intraluminal anisodamine or dobutamine compared with that of the saline controls (41±3. 1)mmHg or (44±3.0)mmHg vs. (49±3.7) mmHg at R30 , (38±3.7)mmHg or (40±2. 1)mmHg vs. (47±3.8) mmHgat R60, (34±2.1) mmHg or (39± 3.0) mmHg vs. (46±3.4) mmHg at R90, respectively,P＜0. 05). The most interesting finding was that there were significantly higher mucosal blood flow and lower jejunal PrCO2 in anisodamine group than those in dobutamine group at 90 minutes of reperfusion (64± 3.3) %vs. (56±4.2)% for blood flow or (34 ± 2.1)mmHg vs. (39 ± 3.0)mmHg for PrCO2, respectively, P＜0.05),suggesting that anisodamine had more lasting effect on mucosal perfusion than dobutamine. Conclusions:Intraluminal anisodamine can augment mucosal blood flow during gut I/R, and it may provide the protective effect on gut from ischemia and reperfusion injury.